LDK378
Ceritinib is an orally available inhibitor of the receptor tyrosine kinase activity of anaplastic lymphoma kinase (ALK) with antineoplastic activity.
Product Specifications
CAS Number
1032900-25-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
558.14
Molecular Formula
C28H36ClN5O3S
Notes
Research use only, not for human use.
Receptor
ALK| FLT3| IGF-1R| Insulin Receptor| STK22D
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LVP1611 1x 10^8 IFU/mL - 200 μL
H HLA-A2 (EF1a, GFP-Puro), Concentrated Lentivirus
Sign In for Pricing
View Details MBS1467301-01 0.02 mg (E-Coli)
Recombinant Legionella pneumophila 5'-nucleotidase surE (surE)
Sign In for Pricing
View Details MBS1467301-02 0.1 mg (E-Coli)
Recombinant Legionella pneumophila 5'-nucleotidase surE (surE)
Sign In for Pricing
View Details MBS1467301-03 0.02 mg (Baculovirus)
Recombinant Legionella pneumophila 5'-nucleotidase surE (surE)
Sign In for Pricing
View Details MBS1467301-04 0.02 mg (Mammalian-Cell)
Recombinant Legionella pneumophila 5'-nucleotidase surE (surE)
Sign In for Pricing
View Details